Orthocell (ASX:OCC) has breakthrough tissue engineering study published in US

2 August 2021
Posted in Media
2 August 2021 Orthocell

Orthocell has been featured in The Market Herald, following the publication of our breakthrough tissue engineering study in the peer-reviewed journal “Proceedings of the National Academy of Sciences of the United States of America”.

Read the article HERE.